| Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox JC Zamora, HR Smith, EM Jennings, TS Chavera, V Kotipalli, A Jay, ... Pharmacology Research & Perspectives 9 (6), e00887, 2021 | 14 | 2021 |
| Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons BA Jacobs, MM Pando, EM Jennings, RJ Jamshidi, JC Zamora, ... Neuropharmacology 151, 208-218, 2019 | 14 | 2019 |
| Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators J Chen, EJ Garcia, CR Merritt, JC Zamora, AA Bolinger, K Pazdrak, ... Journal of medicinal chemistry 66 (14), 9992-10009, 2023 | 5 | 2023 |
| Methocinnamox (MCAM) Is a Selective, Long Acting Antagonist at Mu Opioid Receptors In Vitro JC Zamora, V Kotipalli, EM Jennings, A Disney, S Husbands, G Winger, ... The FASEB Journal 33 (S1), 498.8-498.8, 2019 | 2 | 2019 |
| μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges LM Salinsky, CR Merritt, JC Zamora, JL Giacomini, NC Anastasio, ... Frontiers in Pharmacology 14, 1239159, 2023 | 1 | 2023 |
| Agonist‐dependent modulation by the long‐acting mu opioid receptor antagonist, methocinnamox (MCAM) HR Smith, JC Zamora, TS Chavera, EM Jennings, GD Winger, JH Woods, ... The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
| Serendipitous Discovery of Novel 5-HT2AR Positive Allosteric Modulators (PAMs) Derived From 5-HT2CR PAM Scaffolds JC Zamora, CR Merritt, AA Bolinger, RG Fox, CT Wild, EA Wold, EJ Garcia, ... Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Striatal specific orphan GPCRs crosstalk with Dopamine D2 receptors to regulate cAMP signaling DE Felsing, J Zamora, S Raval, JA Allen The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Long-Term Inhibition of mu Opioid Receptor Function In Vitro and In Vivo by Methocinnamox (MCAM), a Long Acting mu Opioid Receptor Antagonist K Berg, J Zamora, E Jennings, K Varun, W Gail, H Stephen, A Disney, ... NEUROPSYCHOPHARMACOLOGY 43, S372-S372, 2018 | | 2018 |
